PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP

• K. Filonenko,
• I. Kriachok,
• A. Martynchyk,
• I. Titorenko,
• Y. Stepanishyna,
• O. Aleksyk,
• K. Ukianchenko,
• I. Pastushenko,
• Y. Kushchevyy,
• O. Novosad,
• O. Karnabeda,
• I. Diagil,
• V. Kozlov

Affiliations

K. Filonenko

1 Clinic of Hematology and Transplantology, University Clinical Centre, Gdańsk, Poland

I. Kriachok

2 Department of chemotherapy of haemoblastoses and adjuvant treatment methods

A. Martynchyk

2 Department of chemotherapy of haemoblastoses and adjuvant treatment methods

I. Titorenko

2 Department of chemotherapy of haemoblastoses and adjuvant treatment methods

Y. Stepanishyna

3 Oncohematology department with the sector of adjuvant treatment methods

O. Aleksyk

4 Chemotherapy of haemoblastoses and adjuvant treatment methods, National Cancer Institute

K. Ukianchenko

3 Oncohematology department with the sector of adjuvant treatment methods

I. Pastushenko

3 Oncohematology department with the sector of adjuvant treatment methods

Y. Kushchevyy

3 Oncohematology department with the sector of adjuvant treatment methods

O. Novosad

3 Oncohematology department with the sector of adjuvant treatment methods

O. Karnabeda

5 Hematology department, Clinic “Innovation”

I. Diagil

6 Department of Radiation Hematology, National Scientific Center of Radiation Medicine, Kyiv

V. Kozlov

7 Hematology department, Odessa Regional Clinical Hospital, Odessa, Ukraine